
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Pediatricians and schools can be powerful partners in promoting children's health and academic success. Read on to become familiar with school health services and ways to work with school-based personnel to benefit your patients.






